Who Owns INmune Bio Stock?
NASDAQ: INMBHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 15.56%
- Held by insiders
- 10.75%
- Institutional holders
- 97
- Institutions 15.6%
- Insiders 10.8%
- Public and other 73.7%
Who owns INmune Bio stock?
Institutional investors own about 15.6% of INmune Bio's shares, spread across 97 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 10.75% of INMB.
The largest institutional holders are Vanguard Capital Management LLC (2.55%), AQR Capital Management, LLC (2.39%) and Blackrock Inc. (1.12%). Together, the top 10 institutions control 10.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their INMB positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of INMB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 706.42K | 2.55% | +2.8% |
| AQR Capital Management, LLC | 662.22K | 2.39% | +145.0% |
| Blackrock Inc. | 311.61K | 1.12% | -73.9% |
| Raymond James Financial, Inc. | 213.00K | 0.77% | +4.8% |
| Geode Capital Management, LLC | 190.22K | 0.69% | -61.6% |
| Goldman Sachs Group Inc | 185.25K | 0.67% | -20.0% |
| Millennium Management Llc | 159.56K | 0.57% | +100.0% |
| Susquehanna International Group, LLP | 158.45K | 0.57% | -18.5% |
| Jane Street Group, LLC | 134.23K | 0.48% | +163.5% |
| UBS Group AG | 110.41K | 0.40% | -56.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of INMB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 490.27K | 1.77% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 196.00K | 0.71% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 189.55K | 0.68% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 113.71K | 0.41% |
| iShares Trust-iShares Micro-Cap ETF | 81.05K | 0.29% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 29.20K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 26.59K | 0.10% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 20.16K | 0.07% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Growth Index Fund | 19.55K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 11.97K | 0.04% |
Frequently asked questions
Who is the largest shareholder of INmune Bio?
Vanguard Capital Management LLC is the largest institutional shareholder of INMB, owning 2.55% of shares outstanding (706.42K shares) as of its latest 13F filing.
What percentage of INmune Bio is owned by institutions?
Institutions own about 15.6% of INMB shares and 17.4% of the public float.
How much of INmune Bio do insiders own?
Insiders, such as officers and directors, own about 10.75% of INMB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.